Author(s): Maysoon Mohammed Hassan

Email(s): mayalsaraf@gmail.com

DOI: 0.5958/0974-360X.2019.00889.8   

Address: Maysoon Mohammed Hassan
College of Dentistry, Wasit University, Iraq
*Corresponding Author

Published In:   Volume - 12,      Issue - 11,     Year - 2019


ABSTRACT:
One of well knows ant-inflammatory cytokines is Interleukin 4 (IL-4). It plays major roles in the control of immune responses at various levels. It is involved in the proliferation of activated B and T cells, inhibition of type 1 T helper differentiation, and promotion of type 2 T helper cell differentiation, control of B cell maturation (10-13). Moreover, it is involved in the growth, apoptosis, proliferation, and maturation of other hemopoietic and nonhemopoietic cells (14). Previous studies have investigated its role in allergic and autoimmune disorders (14-17). The gene for IL-4 is located at chromosome 5 within the long arm and possesses four exons (18). Several authors have shown a possible association of IL-4 gene polymorphism to a number of clinical disorders such as multiple sclerosis, atopic dermatitis, rheumatoid arthritis, and asthma (19-21). IL- 4 gene polymorphism has been linked to type 1 diabetes mellitus, but we in the current study aimed at investigating the significance of IL-4 590C/T (rs2243250) gene polymorphism in relation to type 2 diabetes and its long term complications. This study was aimed to assess the significance of IL-4 590C/T (rs2243250) gene polymorphism in relation to type 2 diabetes and its long term complications. The present case-control study was carried out at the diabetes center in Al-Diwaniayh Teaching Hospital, Al-Diwaniyah Province, Iraq. The study started in January 2019 and ended on July 2019. The study included 32 types 2 diabetes mellitus patients and 47 apparently healthy control subjects. Five ml sample of venous blood (antecubital vein) was obtained for the purpose of PCR analysis of IL-4 (590-C/T) gene polymorphism. The results of currents study revealed that the distribution of patients with type 2 diabetes was 21 (65.6 %), 9 (28.1 %) and 2 (6.3 %) as CC, CT, and TT genotypes; whereas, the distribution of control subjects was 33 (70.2 %), 10 (21.3 %) and 4 (8.4 %), as CC, CT, and TT genotypes. There was no significant difference in the frequency distribution of diabetic patients and control subjects according to IL- 4rs2243250 genotype (P = 0.757). IL- 4rs2243250 genotype polymorphism was not significantly correlated to retinopathy, nephropathy, neuropathy, CVA, IHD and dyslipidemia (P > 0.05), IL-4 IL- 4rs2243250 genotype polymorphism is neither associated with type 2 diabetes mellitus nor is linked to its long term microvascular and or macrovascular complications.


Cite this article:
Maysoon Mohammed Hassan. The significance of interleukin 4 (IL-4) (590-C/T) gene polymorphism in Iraqi patients with type 2 diabetes mellitus: A case-control study. Research J. Pharm. and Tech. 2019; 12(11):5133-5137. doi: 0.5958/0974-360X.2019.00889.8

Cite(Electronic):
Maysoon Mohammed Hassan. The significance of interleukin 4 (IL-4) (590-C/T) gene polymorphism in Iraqi patients with type 2 diabetes mellitus: A case-control study. Research J. Pharm. and Tech. 2019; 12(11):5133-5137. doi: 0.5958/0974-360X.2019.00889.8   Available on: https://rjptonline.org/AbstractView.aspx?PID=2019-12-11-1


Recomonded Articles:

Author(s): Leelavathi D Acharya, N R Rau, N Udupa, Surulivel Rajan M, Vijayanarayana K

DOI: 10.5958/0974-360X.2016.00162.1         Access: Open Access Read More

Author(s): Vaddi Mounika, S. Sarumathy, J. Anisha Ebens, T. S. Shanmugarajan

DOI: 10.5958/0974-360X.2017.00003.8         Access: Open Access Read More

Author(s): Mohd Yusuf, Mohammad Nasiruddin, Nazneen Sultana, Badruddeen, Juber Akhtar, Mohammad Irfan Khan, Mohammad Ahmad

DOI: 10.5958/0974-360X.2019.00816.3         Access: Open Access Read More

Author(s): Kalaivanan S, Sarumathy S, Anisha Ebens J, Naresh Kumar K, Roobena Parveen A, Nasreen Ashraf M.

DOI: 10.5958/0974-360X.2017.00005.1         Access: Open Access Read More

Author(s): Bhupen Kalita, Malay K. Das, Anil Kumar Sharma

DOI: Not Available         Access: Open Access Read More

Author(s): Razan Ibrahim, Mohammad Imad Khayat, Afraa Zrieki

DOI: 10.5958/0974-360X.2018.00968.X         Access: Open Access Read More

Author(s): Manoj Abraham M, Teh Shiueh Tyng, K. Rekha, Shanmugananth E, Kiruthika S

DOI: 10.5958/0974-360X.2018.01010.7         Access: Open Access Read More

Author(s): Alexander Patera Nugraha, Fianza Rezkita, Martining Shoffa Puspitaningrum, Mahela Sefrian Luthfimaidah, Ida Bagus Narmada, Chiquita Prahasanti, Diah Savitri Ernawati, Fedik Abdul Rantam

DOI: 10.5958/0974-360X.2020.00446.1         Access: Open Access Read More

Author(s): Annette Babu, Ravichandran Veerasamy, Shalini Sivadasan

DOI: 10.5958/0974-360X.2018.00499.7         Access: Open Access Read More

Author(s): Chopade Tanaji, Baokar Shrikrishna, Joshi H.A., Patil R.N.

DOI: 10.5958/0974-360X.2017.00333.X         Access: Open Access Read More

Author(s): Nuri, Bambang Prajogo, Ari S. Nugraha, Sukardiman

DOI: 10.5958/0974-360X.2020.00080.3         Access: Open Access Read More

Author(s): Sanjana Kumar, Rosheni Nair, Samta Gupta, Ahmad Abdullah, Priti Talwar, Palaniyandi Ravanan

DOI: 10.5958/0974-360X.2018.00288.3         Access: Open Access Read More

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags